Related Experiment Video
Updated: May 25, 2026

12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Oncolytic viruses: the power of directed evolution
Maxine Bauzon1, Terry W Hermiston
1Bayer Healthcare, Biologics Research, 455 Mission Bay Boulevard South, San Francisco, CA 94158, USA.
Advances in Virology
|February 8, 2012
Summary
Directed evolution offers a promising alternative to rational design for creating potent oncolytic viruses. This method enhances viral selectivity and therapeutic potential against cancer.
Area of Science:
- Virology
- Oncology
- Biotechnology
Background:
- Rational design of oncolytic viruses has yielded limited success in cancer therapy.
- Developing highly selective and potent anticancer viruses remains a significant challenge.
Purpose of the Study:
- To explore directed evolution as a method for generating effective oncolytic viruses.
- To highlight the benefits of directed evolution using ColoAd1 as a prototype.
- To discuss strategies for enhancing and controlling oncolytic viruses.
Main Methods:
- Employing directed evolution by culturing diverse viruses under simulated cancer microenvironment conditions.
- Selecting and isolating viruses that exhibit enhanced replication and spread in tumor cells.
- Utilizing ColoAd1, a virus developed through directed evolution, as a model system.
Main Results:
- Directed evolution can produce viruses with increased potency and therapeutic windows.
- The latter characteristic, differentiated replication in tumor versus normal cells, defines a true oncolytic virus.
- ColoAd1 serves as a successful example of an oncolytic virus developed via this approach.
Conclusions:
- Directed evolution is a powerful strategy for developing novel oncolytic viruses.
- Further research can focus on "arming" and genetically modulating these evolved viruses for improved cancer treatment.
- This approach offers a promising avenue for advancing oncolytic virotherapy.
Related Concept Videos
Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Conservative Site-specific Recombination and Phase Variation
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
